These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9117548)

  • 1. Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations.
    Strittmatter M; Grauer MT; Hamann GF; Cramer H; Schimrigk K
    Neurodegeneration; 1996 Dec; 5(4):359-66. PubMed ID: 9117548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
    Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
    Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
    Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
    J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy.
    Strittmatter M; Isenberg E; Grauer MT; Hamann G; Schimrigk K
    Neurosci Lett; 1996 Nov; 218(2):99-102. PubMed ID: 8945737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.
    Lee S; Chiba T; Kitahama T; Kaieda R; Hagiwara M; Nagazumi A; Terashi A
    J Neural Transm Suppl; 1990; 30():45-55. PubMed ID: 1697333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
    Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and dementia: clinical and neurochemical correlations.
    Strittmatter MM; Cramer H
    Neuroreport; 1992 May; 3(5):413-6. PubMed ID: 1378766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
    Westenberg HG; Verhoeven WM
    Acta Psychiatr Scand; 1988 Nov; 78(5):541-9. PubMed ID: 2466394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia.
    Strittmatter M; Grauer M; Isenberg E; Hamann G; Fischer C; Hoffmann KH; Blaes F; Schimrigk K
    Headache; 1997 Apr; 37(4):211-6. PubMed ID: 9150615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
    Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
    Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
    Kawakami M; Itoh T
    Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P300 event-related potentials in dementia of the Alzheimer type. Correlations between P300 and monoamine metabolites.
    Ito J; Yamao S; Fukuda H; Mimori Y; Nakamura S
    Electroencephalogr Clin Neurophysiol; 1990; 77(3):174-8. PubMed ID: 1691969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
    Degrell I; Nagy E
    Biol Psychiatry; 1990 Apr; 27(8):891-6. PubMed ID: 1691925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
    Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.